Has Kiran Bath, MD received payments from drug or device companies?

Yes. Drug and device makers reported $165,653 in general payments to Kiran Bath, MD across 457 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kiran Bath, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kiran Bath, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kiran Bath, MD

Neuromusculoskeletal Medicine & OMM · Fullerton, CANPI 1689831380

Payments from drug & device makers

$165,653in general payments, 2019–2025

Across 457 payments — averaging $362.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Acadia Pharmaceuticals Inc$68K
Sanofi$52K
Biohaven Pharmaceuticals, Inc.$17K
AbbVie$12K
Novartis$9K
Abbott$2K
plus $5K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Acadia Pharmaceuticals Inc	25	$68,416
Sanofi	5	$51,550
Biohaven Pharmaceuticals, Inc.	3	$17,434
AbbVie(2 entities)	123	$12,136
Novartis	82	$9,417
Abbott	15	$2,188
AstraZeneca	13	$464
CSL Behring	17	$403
UCB, Inc.	12	$318
Biogen	14	$305
Lilly USA, LLC	13	$288
Argenx US, Inc.	10	$252
Eisai Inc.	10	$241
Pfizer	15	$230
Bristol Myers Squibb	10	$215
Teva Pharmaceuticals USA, Inc.	8	$180
Genentech, Inc.	7	$140
SK Life Science, Inc.	5	$139
Banner Life Sciences, LLC	12	$133
Biohaven Pharmaceutical Holding Company Ltd.	12	$123
TG Therapeutics, Inc.	5	$113
MDD US Operations, LLC	5	$93
Lundbeck LLC	3	$65
Merz Pharmaceuticals, LLC	2	$58
Harmony Biosciences LLC	1	$48
Neurocrine Biosciences, Inc.	2	$46
Jazz Pharmaceuticals Inc.	2	$46
Kyowa Kirin, Inc.	2	$45
Amgen(2 entities)	2	$43
Neuropace, Inc.	1	$42
Amneal Pharmaceuticals LLC	2	$42
Tanabe Pharma America, Inc.	2	$38
GE HealthCare	1	$37
Catalyst Pharmaceuticals, Inc.	1	$35
Takeda Pharmaceuticals U.S.A., Inc.	2	$34
Corium, LLC	1	$33
Amylyx Pharmaceuticals, Inc.	1	$32
Genentech USA, Inc.	1	$28
Insightec,inc	1	$28
Impel Pharmaceuticals Inc.	2	$28
Johnson & Johnson	1	$26
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$25
Supernus Pharmaceuticals, Inc.	1	$25
Microtransponder, Inc.	1	$22
Cala Health, Inc.	1	$19
Sunovion Pharmaceuticals Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$12

How this compares

$165,653 in reported general payments places this provider in the 95th percentile of 113 neuromusculoskeletal medicine & omm providers in California.

See all neuromusculoskeletal medicine & omm providers in California →

Medicare billing

Part B allowed, 2024

$134,405

Medicare patients

375

Services billed

903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuromusculoskeletal medicine & omm in Fullerton

Raffy MirzayanBaldwin Park$458K
Dean MatsudaLos Angeles$452K
Scott ShoemakerSan Diego$49K
Narendra GurbaniBellflower$40K
Richard DellBellflower$15K
Emil DionysianAnaheim$14K
Richard HartmanSanta Barbara$6K
Gary JenkinsOroville$5K
Neil HarnessAnaheim$4K
William OharaSan Diego$4K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →